Remarkably, a previous study reported that a decrease in FTO in the GCs of patients with premature ovarian insufficiency increased the total amount of m6A [37], while another study reported that alkylating agents could increase the abundance of m6A modifications in GCs [38]. The gene discussed is FTO; the disease is Premature ovarian insufficiency.